Comparing Ipilimumab vs Zelboraf
Ipilimumab |
Zelborafvemurafenib |
||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Melanoma - Metastatic, Melanoma. ipilimumab may also be used for purposes not listed in this medication guide. |
Prescribed for Melanoma - Metastatic, Erdheim-Chester Disease. Zelboraf may also be used for purposes not listed in this medication guide. |
||||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||
|
N/A |
6.6
|
||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
See the full ipilimumab side effects document. |
Common side effects include: squamous cell carcinoma, keratoacanthoma, skin photosensitivity, and erythema. See the full Zelboraf side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
||||||||
Generic Availability |
|||||||||
|
No |
No |
||||||||
Dosage Form(s) Available |
|||||||||
| N/A |
|
||||||||
Brand Names |
|||||||||
| Yervoy |
N/A |
||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
352.8 hours |
120 hours |
||||||||
CSA ScheduleView glossary of terms. |
|||||||||
|
N
Not a controlled drug
Is not subject to the Controlled Substances Act. |
N
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
C
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
D
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||
FDA Alerts |
|||||||||
|
N/A |
N/A |
||||||||
Drug Interactions |
|||||||||
|
A total of 137 drugs are known to interact with ipilimumab:
|
A total of 859 drugs are known to interact with Zelboraf:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
No results found - however, this does not necessarily mean no warnings exist. Always consult with your doctor or pharmacist. |
No results found - however, this does not necessarily mean no warnings exist. Always consult with your doctor or pharmacist. |
||||||||
Disease Interactions |
|||||||||
First Approval Date |
|||||||||
|
N/A |
August 17, 2011 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Consumer Resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
For Melanoma, Metastatic Cancer returned (metastasized) in abdomen Sept 2011. I ended up in hospital, first parenthesis withdrew 10 liters of abdominal fluid. Given 5 months maximum to live. It is now April 2012. Zelboraf has extended and saved my life. I've been told by specialist in Denver (university of Colorado hospital) that in Europe 42 month life extension has been documented at present time. By dosing with 2 x 240mg pills twice a day! I'd be dead if not for Zelboraf!